Adverse Effects of Combined Tyrosine Kinase Inhibitors

被引：0
|
作者：
Lu, Shun [1 ]
Li, Ziming [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2020年 / 15卷 / 11期
关键词：
INTERSTITIAL LUNG-DISEASE; CANCER; C797S; GEFITINIB; T790M;
D O I：
10.1016/j.jtho.2020.07.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E182 / E183
页数：2
相关论文
共 50 条
  • [1] Overview and Management of Cardiac Adverse Events Associated With Tyrosine Kinase Inhibitors
    Lenihan, Daniel J.
    Kowey, Peter R.
    ONCOLOGIST, 2013, 18 (08) : 900 - 908
  • [2] Tyrosine kinase inhibitors
    Hantraye, Benedicte
    Leroux, Amelie
    Clere, Nicolas
    ACTUALITES PHARMACEUTIQUES, 2015, 54 (551): : 22 - 27
  • [3] Side effects of tyrosine kinase inhibitors in cancer treatment
    Mencinger, Marina
    ONKOLOGIJA, 2018, 22 (01) : 24 - 27
  • [4] Theoretical method for evaluation of therapeutic effects and adverse effects of epidermal growth factor receptor tyrosine kinase inhibitors in clinical treatment
    Kimura, Koji
    Takayanagi, Risa
    Fukushima, Tomoki
    Yamada, Yasuhiko
    MEDICAL ONCOLOGY, 2017, 34 (10)
  • [5] Theoretical method for evaluation of therapeutic effects and adverse effects of epidermal growth factor receptor tyrosine kinase inhibitors in clinical treatment
    Koji Kimura
    Risa Takayanagi
    Tomoki Fukushima
    Yasuhiko Yamada
    Medical Oncology, 2017, 34
  • [6] Pharmacology of Tyrosine Kinase Inhibitors
    Hulin, Anne
    Gele, Thibaut
    Fenioux, Charlotte
    Kempf, Emmanuelle
    Sahali, Dil
    Tournigand, Christophe
    Ollero, Mario
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (07): : 927 - 938
  • [7] Tyrosine Kinase Inhibitors for the Elderly
    Hohenforst-Schmidt, Wolfgang
    Zarogoulidis, Paul
    Steinheimer, Michael
    Benhassen, Naim
    Tsiouda, Theodora
    Baka, Sofia
    Yarmus, Lonny
    Stratakos, Grigoris
    Organtzis, John
    Pataka, Athanasia
    Tsakiridis, Kosmas
    Karapantzos, Ilias
    Karapantzou, Chrysanthi
    Darwiche, Kaid
    Zissimopoulos, Athanasios
    Pitsiou, Georgia
    Zarogoulidis, Konstantinos
    Man, Yan-Gao
    Rittger, Harald
    JOURNAL OF CANCER, 2016, 7 (06): : 687 - 693
  • [8] Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UK
    R. Califano
    N. Tariq
    S. Compton
    D. A. Fitzgerald
    C. A. Harwood
    R. Lal
    J. Lester
    J. McPhelim
    C. Mulatero
    S. Subramanian
    A. Thomas
    N. Thatcher
    M. Nicolson
    Drugs, 2015, 75 : 1335 - 1348
  • [9] Progress in Research on Protein Tyrosine Kinase Inhibitors Progress in Research on Protein Tyrosine Kinase Inhibitors
    Chen, Yu
    INTERNATIONAL CONFERENCE ON FRONTIERS OF BIOLOGICAL SCIENCES AND ENGINEERING (FBSE 2018), 2019, 2058
  • [10] Combined anticancer effects of sphingosine kinase inhibitors and sorafenib
    Beljanski, Vladimir
    Knaak, Christian
    Zhuang, Yan
    Smith, Charles D.
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (06) : 1132 - 1142
12345